The clinical impact of comorbidities among patients with idiopathic pulmonary fibrosis undergoing anti-fibrotic treatment: A multicenter retrospective observational study.

Ayako AokiYu HaraHiroaki FujiiKota MurohashiRyo NagasawaYoichi TagamiTatsuji EnomotoYutaka MatsumotoMakoto MasudaKeisuke WatanabeNobuyuki HoritaNobuaki KobayashiMakoto KudoTakashi OguraTakeshi Kaneko

Published in: PloS one (2023)

In the present study, we could not show any relation between CCIS and IPF disease outcomes in patients undergoing AFT, though the longer duration of AFT might be beneficial for IPF outcomes among patients with low CCIS.

Keyphrases

idiopathic pulmonary fibrosis
patients undergoing
interstitial lung disease
cross sectional
type diabetes
adipose tissue
combination therapy
clinical trial
double blind
insulin resistance
replacement therapy